Report Scope & Overview:
The Intensive Care Unit (ICU) Market size was valued at $ 3.10 Bn in 2022 and is expected to reach $ 9.45 Bn by 2030, and grow at CAGR of 14.5 % over the forecast period of 2023-2030.
Patients in an intensive care unit (ICU) are those who have serious, life-threatening diseases that call for round-the-clock observation, sophisticated medical treatments, and close supervision by a group of particularly qualified healthcare experts. A critical component of an ICU is Advanced Monitoring, Vital signs like heart rate, blood pressure, oxygen levels, and more are continuously tracked for ICU patients utilising a variety of medical devices. Due to this ongoing observation, medical personnel are able to react rapidly to any changes in the patient's condition. Modern medical technology is available in ICUs, including dialysis machines for patients with kidney failure and ventilators for patients who need mechanical breathing help.
A multidisciplinary group of highly skilled medical professionals, including critical care doctors, nurses, respiratory therapists, and other experts, work in the ICU. These experts collaborate to give patients around-the-clock treatment. ICU patients frequently need sophisticated medical treatments, such as the administration of medications, completion of intricate operations, and use of cutting-edge techniques. The objective is to maintain and enhance the patient's health while averting future decline. The compromised immune systems of many ICU patients make them vulnerable to infections. To reduce the risk of infection spreading among patients, ICUs frequently implement stringent infection control procedures.
The ICU team is aware of how crucial it is to communicate with the patient's family. There may be restrictions on visiting and communicating, nevertheless, given the seriousness of the patients' diseases and the necessity to give patient care top priority. Critical Care Units: ICUs can be specialised to treat particular types of critical cases. For example, cardiac ICUs (CICUs) are for conditions relating to the heart, surgical ICUs (SICUs) are for post-operative care, and neonatal ICUs (NICUs) are for preterm infants. By offering specialised treatment to patients who need acute medical attention, intensive care units (ICUs) serve an important role in the healthcare system. Stabilising their condition, administering therapy, and eventually moving patients to less intensive care or general hospital wards after their health improves are the objectives.
The rise in the demand for the ICU as there is an increase in the aging population has been noticed.
Chronic illnesses and ailments that call for intense care are more common as the population ages. The health needs of older people are frequently more complex, and they can need intensive care unit (ICU) care for issues like heart failure, respiratory illnesses, and post-surgical recuperation. Medical technology improvements have resulted in the creation of novel therapies and interventions that call for specialised care, which is frequently given in the intensive care unit (ICU). This covers cutting-edge surgical techniques, organ transplantation, and the utilisation of cutting-edge medical equipment.
The high cost of the ICU.
The advancement in the healthcare industry.
Post-operative intensive care is frequently needed for monitoring and healing after complex surgeries such heart operations, brain surgeries, and organ transplants. The need for these specialised post-operative ICU treatments may rise as surgical methods advance. Patients and their families have higher expectations for medical care than ever before, including access to cutting-edge therapies and specialised services like intensive care units (ICUs).
The lack of access in the emerging and the undeveloped regions
Impact of Recession
Recessions can cause job losses and income reductions, which can cause a greater number of people to lose their health care coverage. This can cause medical care, especially ICU services, to be delayed or less accessible. The patient load in intensive care units (ICUs) may rise for a variety of reasons, depending on the type and severity of the recession. Increased stress and mental health problems brought on by job losses may raise demand for critical care services. Budget restrictions, however, may also result in a decline in ICU personnel, which would have an impact on the level of care that can be delivered. Recessions can impair the availability of medical supplies and equipment required in ICUs by upsetting global supply systems. a lack of something crucial.
Impact of Russia Ukraine War.
The healthcare system may be under stress in areas directly impacted by the conflict as a result of an increase in civilian and combatant deaths. Critically injured patients may swell up in ICUs, taxing their capacity and resources. Medical Supply Chain Disruption: Conflict can interfere with the flow of medical supplies, including drugs, equipment, and other necessities for intensive care units. Critical item shortages can have an impact on the standard of care and the feasibility of performing actions that could save lives. Limited Access to Specialised Care: Obstacles associated to conflict may hinder the movement of patients and medical personnel. This would prevent patients from receiving specialised care, such as ICU services, which would delay treatment and possibly have worse results.
Open with Consultants
Rest of Eastern Europe
Rest of Western Europe
Rest of Asia Pacific
Middle East & Africa
Rest of Middle East
Rest of Africa
Rest of Latin America
The major key players are Advanced ICU care, INOVA, Banner Health, Philips, iMDsoft, InTouch health, UPMC Italy, VISICU, Tele-ICU, INTELEICU and others.
INOVA-Company Financial Analysis
North America region will be the region with the highest share. The rising aging population and at the same time the rise in the number of people suffering from chronic disease which is inviting the opportunity for the ICU is the driving factor. Also, the implementation of the latest technologies in the healthcare infrastructure in order to improve the overall healthcare is also contributing to the growth of the market in this region.
APAC region will be the region with the highest CAGR growth rate because of the rising infrastructure plans and programs of the private and the government organizations. The rising awareness of the benefits which is associated with the ICU in terms of special care and monitoring of the patient carefully are the factors which is letting the market to attract the potential growth in terms of value.
Advanced ICU care: The company announces corporate Rebrand as Hicuity Health.
iMDsoft – The company expand its presence in Europe by selecting Polska as channel partner in Poland.
|Market Size in 2022||US$ 3.10 Bn|
|Market Size by 2030||US$ 9.45 Bn|
|CAGR||CAGR of 14.5 % From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Type (Intensivist, Open with Consultants)
• By Component (Hardware, Software)
|Regional Analysis/Coverage||North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)|
|Company Profiles||Advanced ICU care, INOVA, Banner Health, Philips, iMDsoft, InTouch health, UPMC Italy, VISICU, Tele-ICU, INTELEICU|
|Key Drivers||• The rise in the demand for the ICU as there is an increase in the aging population has been noticed.|
|Market Restraints||• The high cost of the ICU.|
Ans. The Compound Annual Growth rate for ICU Market over the forecast period is 14.5%.
Ans. USD 9.45 Billion is the projected ICU market size of market by 2030.
Ans. The major key players are Advanced ICU care, INOVA, Banner Health, Philips, iMDsoft, InTouch health, UPMC Italy, VISICU, Tele-ICU, ITELEICU and others.
Ans. North America is the fastest growing region of the ICU Market.
Ans. The advancement in the healthcare industry.
TABLE OF CONTENT
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.2 Impact on major economies
18.104.22.168 United Kingdom
22.214.171.124 South Korea
126.96.36.199 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. ICU Market Segmentation, by Type
8.2 Open with Consultants
9. ICU Market Segmentation, by Component
10. Regional Analysis
10.2 North America
10.2.1 North America ICU Market by Country
10.2.2 North America ICU Market by Type
10.2.3 North America ICU Market by Component
10.2.4.1 USA ICU Market by Type
10.2.4.2 USA ICU Market by Component
10.2.5.1 Canada ICU Market by Type
10.2.5.2 Canada ICU Market by Component
10.2.6.1 Mexico ICU Market by Type
10.2.6.2 Mexico ICU Market by Component
10.3.1 Eastern Europe
10.3.1.1 Eastern Europe ICU Market by Country
10.3.1.2 Eastern Europe ICU Market by Type
10.3.1.3 Eastern Europe ICU Market by Component
10.3.1.4.1 Poland ICU Market by Type
10.3.1.4.2 Poland ICU Market by Component
10.3.1.5.1 Romania ICU Market by Type
10.3.1.5.2 Romania ICU Market by Component
10.3.1.6.1 Hungary ICU Market by Type
10.3.1.6.2 Hungary ICU Market by Component
10.3.1.7.1 Turkey ICU Market by Type
10.3.1.7.2 Turkey ICU Market by Component
10.3.1.8 Rest of Eastern Europe
10.3.1.8.1 Rest of Eastern Europe ICU Market by Type
10.3.1.8.2 Rest of Eastern Europe ICU Market by Component
10.3.2 Western Europe
10.3.2.1 Western Europe ICU Market by Country
10.3.2.2 Western Europe ICU Market by Type
10.3.2.3 Western Europe ICU Market by Component
10.3.2.4.1 Germany ICU Market by Type
10.3.2.4.2 Germany ICU Market by Component
10.3.2.5.1 France ICU Market by Type
10.3.2.5.2 France ICU Market by Component
10.3.2.6.1 UK ICU Market by Type
10.3.2.6.2 UK ICU Market by Component
10.3.2.7.1 Italy ICU Market by Type
10.3.2.7.2 Italy ICU Market by Component
10.3.2.8.1 Spain ICU Market by Type
10.3.2.8.2 Spain ICU Market by Component
10.3.2.9.1 Netherlands ICU Market by Type
10.3.2.9.2 Netherlands ICU Market by Component
10.3.2.10.1 Switzerland ICU Market by Type
10.3.2.10.2 Switzerland ICU Market by Component
10.3.2.11.1 Austria ICU Market by Type
10.3.2.11.2 Austria ICU Market by Component
10.3.2.12 Rest of Western Europe
10.3.2.12.1 Rest of Western Europe ICU Market by Type
10.3.2.12.2 Rest of Western Europe ICU Market by Component
10.4.1 Asia Pacific ICU Market by Country
10.4.2 Asia Pacific ICU Market by Type
10.4.3 Asia Pacific ICU Market by Component
10.4.4.1 China ICU Market by Type
10.4.4.2 China ICU Market by Component
10.4.5.1 India ICU Market by Type
10.4.5.2 India ICU Market by Component
10.4.6.1 Japan ICU Market by Type
10.4.6.2 Japan ICU Market by Component
10.4.7 South Korea
10.4.7.1 South Korea ICU Market by Type
10.4.7.2 South Korea ICU Market by Component
10.4.8.1 Vietnam ICU Market by Type
10.4.8.2 Vietnam ICU Market by Component
10.4.9.1 Singapore ICU Market by Type
10.4.9.2 Singapore ICU Market by Component
10.4.10.1 Australia ICU Market by Type
10.4.10.2 Australia ICU Market by Component
10.4.11 Rest of Asia-Pacific
10.4.11.1 Rest of Asia-Pacific ICU Market by Type
10.4.11.2 Rest of Asia-Pacific ICU Market by Component
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 Middle East ICU Market by Country
10.5.1.2 Middle East ICU Market by Type
10.5.1.3 Middle East ICU Market by Component
10.5.1.4.1 UAE ICU Market by Type
10.5.1.4.2 UAE ICU Market by Component
10.5.1.5.1 Egypt ICU Market by Type
10.5.1.5.2 Egypt ICU Market by Component
10.5.1.6 Saudi Arabia
10.5.1.6.1 Saudi Arabia ICU Market by Type
10.5.1.6.2 Saudi Arabia ICU Market by Component
10.5.1.7.1 Qatar ICU Market by Type
10.5.1.7.2 Qatar ICU Market by Component
10.5.1.8 Rest of Middle East
10.5.1.8.1 Rest of Middle East ICU Market by Type
10.5.1.8.2 Rest of Middle East ICU Market by Component
10.5.2.1 Africa ICU Market by Country
10.5.2.2 Africa ICU Market by Type
10.5.2.3 Africa ICU Market by Component
10.5.2.4.1 Nigeria ICU Market by Type
10.5.2.4.2 Nigeria ICU Market by Component
10.5.2.5 South Africa
10.5.2.5.1 South Africa ICU Market by Type
10.5.2.5.2 South Africa ICU Market by Component
10.5.2.6 Rest of Africa
10.5.2.6.1 Rest of Africa ICU Market by Type
10.5.2.6.2 Rest of Africa ICU Market by Component
10.6 Latin America
10.6.1 Latin America ICU Market by Country
10.6.2 Latin America ICU Market by Type
10.6.3 Latin America ICU Market by Component
10.6.4.1 Brazil ICU Market by Type
10.6.4.2 Brazil ICU Market by Component
10.6.5.1 Argentina ICU Market by Type
10.6.5.2 Argentina ICU Market by Component
10.6.6.1 Colombia ICU Market by Type
10.6.6.2 Colombia ICU Market by Component
10.6.7 Rest of Latin America
10.6.7.1 Rest of Latin America ICU Market by Type
10.6.7.2 Rest of Latin America ICU Market by Component
11 Company Profile
11.1 Advanced ICU care
11.1.1 Company Overview
11.1.3 Product/Services Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2.1 Company Overview
11.2.3 Product/Services Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 Banner Health
11.3.1 Company Overview
11.3.3 Product/Services Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Company Overview
11.4.3 Product/Services Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5.1 Company Overview
11.5.3 Product/Services Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 InTouch health
11.6.1 Company Overview
11.6.3 Product/Services Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 UPMC Italy
11.7.1 Company Overview
11.7.3 Product/Services Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8.1 Company Overview
11.8.3 Product/Services Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9.1 Company Overview
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10.1 Company Overview
11.10.3 Product/Services Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View
12. Competitive Landscape
12.1 Competitive Bench marking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. USE Cases and Best Practices
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Foley Catheter Market size was estimated USD 1.63 billion in 2022 and is expected to reach USD2.56 billion by 2030 at a CAGR of 5.8% during the forecast period of 2023-2030.
The Consumer Healthcare market size was valued at USD 278 billion in 2022 and is expected to reach USD 492.12 billion by 2030 and grow at a CAGR of 7.4% over the forecast period of 2023-2030.
The Autoimmune Disease Testing Market size was valued at USD 10.2 billion in 2022 and it is expected to be worth around USD 22.18 billion by 2030 growing at a remarkable GAGR of 10.2% over the forecast period 2023-2030.
The Albumin Market size was estimated USD 0.9 billion in 2022 and is expected to reach USD 1.43 billion by 2030 at a CAGR of 6.0% during the forecast period of 2023-2030.
The Particle Counter Market Size was valued at USD 418.38 million in 2022, and is expected to reach USD 903.37 million by 2030 and grow at a CAGR of 10.1% over the forecast period 2023-2030.
The Personalized Medicine Market size was estimated USD 300 billion in 2022 and is expected to reach USD 691.3 billion by 2030 at a CAGR of 11.0% during the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone